In a cyberattack on Europe’s medicines regulator, Pfizer and its German partner BioNTech said that documents related to coronavirus vaccine development on Wednesday had been “unlawfully accessed”.
The European Medicines Agency (EMA), which allows and approves medicines and vaccines for the Europen Union, said that it had been targeted in a cyberattack. It did not reveal any more details regarding the matter.
Moreover, Pfizer and BioNTech believed that no personal data of trial participants had been leaked and EMA “has assured us that the cyber attack will have no impact on the timeline for its review.”
It was not clear that when or how the EMA was attacked, or who was the culprit behind the cyberattack.
BioNTech spokeswoman had declined further comment and Pfizer also did not reply immediately to a request for more comment.
[embedpost slug=”how-will-pfizer-biontech-be-used-next-week/”]
